We are live on ! Find out more
CD

Chapin Davis Portfolio holdings

AUM $520M Turnover 15.11%
1-Year Est. Return 117.57%
This Fund
S&P 500
This Quarter Est. Return
+70.07%
1 Year Est. Return
+117.57%
3 Year Est. Return
+339.14%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$569M
AUM Growth
+$120M
Cap. Flow
-$25.6M
Cap. Flow %
-4.5%
Top 10 Hldgs %
35.59%
Holding
285
New
24
Increased
84
Reduced
92
Closed
29
Avg Time Held
2.3 years
Top 10 Avg Time Held
0.5 years
Top 20 Avg Time Held
1.2 years

Top Buys

Rank Stock Value
1
SNDK icon
Sandisk
SNDK
+$12.6M
2
MU icon
Micron Technology
MU
+$11.8M
3
FLEX icon
Flex
FLEX
+$11.8M
4
DDOG icon
Datadog
DDOG
+$10.8M
5
MRVL icon
Marvell Technology
MRVL
+$10.1M

Top Sells

Rank Stock Value
1
TER icon
Teradyne
TER
+$11.8M
2
GLW icon
Corning
GLW
+$10.5M
3
ALB icon
Albemarle
ALB
+$9.23M
4
CIEN icon
Ciena
CIEN
+$8.91M
5
WDC icon
Western Digital
WDC
+$8.21M

Sector Composition

Rank Sector Weight
1 Technology 51.72%
2 Miscellaneous 16.37%
3 Financials 6.56%
4 Industrials 6.26%
5 Healthcare 4.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
MYI icon
251
BlackRock MuniYield Quality Fund III
MYI
$1.2B
$117K 0.02%
10,500
– –
2026 Q1
1 quarter
SRTS icon
252
Sensus Healthcare
SRTS
$45.6M
$78.5K 0.01%
26,000
– –
2024 Q2
8 quarters
HRZN icon
253
Horizon Technology Finance
HRZN
$308M
$60K 0.01%
+12,691
New +$54.9K
2026 Q2
0 quarters
YCBD icon
254
cbdMD
YCBD
$4.03M
$54.7K 0.01%
81,250
– –
2025 Q2
4 quarters
MGF
255
Aberdeen Government Markets Income Fund
MGF
$88.1M
$37.5K 0.01%
2,610
– –
2022 Q4
14 quarters
LCTX icon
256
Lineage Cell Therapeutics
LCTX
$250M
$26.2K ﹤0.01%
20,029
– –
2025 Q1
5 quarters
ADI icon
257
Analog Devices
ADI
$196B
– –
-995
Closed -$317K –
ALB icon
258
Albemarle
ALB
$11.6B
– –
-51,439
Closed -$9.23M –
APH icon
259
Amphenol
APH
$201B
– –
-9,832
Closed -$621K –
CALM icon
260
Cal-Maine
CALM
$2.97B
– –
-5,475
Closed -$433K –
CDE icon
261
Coeur Mining
CDE
$15.8B
– –
-11,150
Closed -$209K –
CF icon
262
CF Industries
CF
$18.1B
– –
-53,400
Closed -$6.93M –
CIEN icon
263
Ciena
CIEN
$50.6B
– –
-22,959
Closed -$8.91M –
DE icon
264
Deere & Co
DE
$175B
– –
-1,453
Closed -$819K –
EEM icon
265
iShares MSCI Emerging Markets ETF
EEM
$29.6B
– –
-8,962
Closed -$509K –
EW icon
266
Edwards Lifesciences
EW
$50.8B
– –
-7,610
Closed -$609K –
FCX icon
267
Freeport-McMoran
FCX
$101B
– –
-19,006
Closed -$1.12M –
GSK icon
268
GSK
GSK
$98.2B
– –
-7,988
Closed -$441K –
HIO icon
269
Western Asset High Income Opportunity Fund
HIO
$313M
– –
-26,909
Closed -$97.7K –
INGR icon
270
Ingredion
INGR
$6.13B
– –
-4,130
Closed -$465K –
INTU icon
271
Intuit
INTU
$88.2B
– –
-723
Closed -$313K –
LDOS icon
272
Leidos
LDOS
$15.6B
– –
-1,600
Closed -$249K –
LITE icon
273
Lumentum
LITE
$78.8B
– –
-9,765
Closed -$6.86M –
MMM icon
274
3M
MMM
$85.3B
– –
-2,271
Closed -$330K –
MRCC icon
275
DELISTED
Monroe Capital Corp
MRCC
– –
-13,500
Closed -$62.1K –
8 9 10
11
12

Similar funds

AIS
AM Investment Strategies Chattanooga, Tennessee $521M AUM 33.22% 1-Year Est. Return
SWM
Scissortail Wealth Management Tulsa, Oklahoma $520M AUM 21.73% 1-Year Est. Return
CFA
Churchill Financial Advisors Louisville, Kentucky $519M AUM
VP
venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return
CFG
Compton Financial Group Towson, Maryland $519M AUM 14.76% 1-Year Est. Return
MWM
Mindset Wealth Management Indianapolis, Indiana $519M AUM 46.03% 1-Year Est. Return
LCWP
Legacy Capital Wealth Partners Little Rock, Arkansas $521M AUM 28.27% 1-Year Est. Return
WS
Wendel SE Paris $519M AUM 48.2% 1-Year Est. Return

Chapin Davis's Q2 2026 Portfolio in Review

As of Q2 2026, Chapin Davis held 285 positions worth $569M, up 27% from $449M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Chapin Davis withdrew a net $25.6M in Q2 2026, closing 29 positions and reducing 92 holdings. Its most notable exit was Albemarle, an estimated $9.23M position sold in full.

By sector, the portfolio is most concentrated in Technology at 52% of assets, up from 35% a quarter earlier, followed by Miscellaneous and Financials.

Against the trend, Chapin Davis opened a new position in Flex worth $15.8M.

  • Chapin Davis's largest Q2 2026 buy was Flex: 97,607 shares worth $15.8M.
  • Chapin Davis added most to Sandisk in Q2 2026, an estimated $12.6M increase.
  • Chapin Davis's biggest Q2 2026 reduction was Teradyne, cutting an estimated $11.8M.
  • Chapin Davis fully exited Albemarle in Q2 2026, selling an estimated $9.23M.
  • Chapin Davis's ten largest holdings make up 36% of its $569M portfolio in Q2 2026.
  • Chapin Davis opened 24 new positions and closed 29 in Q2 2026.
  • Chapin Davis's portfolio value rose 27% quarter-over-quarter to $569M.

Based on Chapin Davis's 13F filing for Q2 2026, filed 7 Jul 2026.